# US 2018/0023130 A1 · Nicking and Extension Amplification Reaction for the Exponential Amplification of Nucleic Acids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0023130 A1
- Document ID: US20180023130A1
- Status: Published application
- Kind: A1
- Application number: 15/467,893
- Filed: 2017-03-23
- Published: 2018-01-25
- Earliest claimed: 2007-07-14
- Applicants: Ionian Technologies, Inc.
- Inventors: Brian K. Maples; Rebecca C. Holmberg; Andrew P. Miller; Jarrod Provins; Richard Roth; Jeffrey Mandell
- Web page: https://patentgrep.com/patent/US20180023130A1

## CPC

- C12Q 1/6844: Nucleic acid amplification reactions
- C07H 21/04: with deoxyribosyl as saccharide radical
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- G01N 30/72: Mass spectrometers {(mass spectrometers per se H01J49/00)}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention is in general directed to the rapid exponential amplification of short DNA or RNA sequences at a constant temperature.

## Claims

### Claim at position 1

-41. (canceled)

### Claim 42

A method of amplifying a target nucleotide sequence, the method comprising:
(a) combining a target nucleic acid comprising the target nucleotide sequence with an amplification reagent mixture comprising:
i. a polymerase,
ii. one or more nicking enzymes,
iii. a first oligonucleotide comprising a 5′ portion that comprises a nicking site that is non-complementary to the target nucleotide sequence and a 3′ portion that hybridizes to the target nucleotide sequence, and
iv. a second oligonucleotide comprising a 5′ portion that comprises a nicking site that is non-complementary to the target nucleotide sequence and a 3′ portion that hybridizes to the target nucleotide sequence, and
(b) subjecting the reaction mixture formed by the step of combining to essentially isothermal conditions to amplify the target nucleotide sequence;
wherein:
the target nucleotide sequence is between 20 and 40 nucleotides in length; and
(ii) the target nucleotide sequence is amplified 1E+6-fold or more in about in about ten minutes.

### Claim 43 (depends on 42)

The method of claim 42, wherein no oligonucleotides other than the first oligonucleotide and the second oligonucleotide are necessary to amplify the target nucleotide sequence.

### Claim 44 (depends on 42)

The method of claim 42, wherein the amplification reagent mixture contains no oligonucleotides other than the first oligonucleotide and the second oligonucleotide.

### Claim 45 (depends on 42)

The method of claim 42, wherein the target nucleic acid is present in a sample obtained from an animal, plant or food.

### Claim 46 (depends on 42)

The method of claim 42, wherein the target nucleic acid is not subjected to a thermal denaturation step prior to the step of combining.

### Claim 47 (depends on 42)

The method of claim 42, wherein the step of combining occurs in a single step.

### Claim 48 (depends on 45)

The method of claim 45, wherein the target nucleic acid is present in a sample obtained from an animal and the obtained sample is diluted prior to the step of combining.

### Claim 49 (depends on 42)

The method of claim 42, wherein the amplification reagent mixture is free of bumper primers.

### Claim 50 (depends on 42)

The method of claim 42, wherein the target nucleotide sequence is amplified without the assistance of bumper primers.

### Claim 51 (depends on 42)

The method of claim 42, further comprising (c) detecting the amplified target nucleotide sequence within about 10 minutes or less of subjecting the reaction mixture formed by the step of combining to essentially isothermal conditions.

### Claim 52 (depends on 51)

The method of claim 51, wherein (c) detecting the amplified target nucleotide sequence occurs in real time.

### Claim 53 (depends on 45)

The method of claim 45, wherein the sample is obtained from an animal and the animal is a human, the target nucleic acid is a target nucleic acid of a human pathogen, and the sample is obtained from the mucus, sputum, or saliva of the human.

### Claim 54 (depends on 53)

The method of claim 53, wherein the human pathogen is a single-stranded DNA virus, double-stranded DNA virus, or a single-stranded RNA virus.

### Claim 55 (depends on 53)

The method of claim 53, wherein the human pathogen is a bacterium.

### Claim 56 (depends on 42)

The method of claim 42, wherein the first oligonucleotide further comprises a nicking enzyme binding site and a stabilizing region.

### Claim 57 (depends on 42)

The method of claim 42, wherein the second oligonucleotide further comprises a nicking enzyme binding site and a stabilizing region.

### Claim 58 (depends on 56)

The method of claim 56, wherein the one or more nicking enzymes nicks downstream of the nicking enzyme binding site.

### Claim 59 (depends on 57)

The method of claim 57, wherein the one or more nicking enzymes nicks downstream of the nicking enzyme binding site.

### Claim 60 (depends on 42)

The method of claim 42, wherein each of the first oligonucleotide and the second oligonucleotide comprises a nicking enzyme binding site recognized by the same nicking enzyme and the one or more nicking enzymes are the same.

### Claim 61 (depends on 42)

The method of claim 42, wherein the 3′ portion of the first oligonucleotide that hybridizes to the target nucleotide sequence is 8-15 nucleotides long.

### Claim 62 (depends on 42)

The method of claim 42, wherein the 3′ portion of the second oligonucleotide that hybridizes to the target nucleotide sequence is 8-15 nucleotides long.

### Claim 63 (depends on 42)

The method of claim 42, wherein the target nucleic acid is double-stranded DNA.

### Claim 64 (depends on 42)

The method of claim 42, wherein the target nucleic acid is single-stranded DNA.

### Claim 65 (depends on 42)

The method of claim 42, wherein the target nucleic acid is RNA.

### Claim 66 (depends on 42)

The method of claim 42, wherein the target nucleic acid is selected from the group consisting of genomic DNA, plasmid DNA, viral DNA, mitochondrial DNA, cDNA, synthetic double-stranded DNA and synthetic single-stranded DNA.

### Claim 67 (depends on 42)

The method of claim 42, wherein the target nucleic acid is selected from the group consisting of messenger RNA, viral RNA, ribosomal RNA, transfer RNA, micro RNA, micro RNA precursor, and synthetic RNA.

### Claim 68 (depends on 42)

The method of claim 42, wherein the temperature of the essentially isothermal conditions is between 54° C. and 60° C.

### Claim 69 (depends on 42)

The method of claim 42, wherein the temperature of the essentially isothermal conditions is between 56° C. and 58° C.

### Claim 70 (depends on 42)

The method of claim 42, wherein at least two different target nucleotide sequences are amplified.

### Claim 71 (depends on 42)

The method of claim 42, wherein the target nucleotide sequence is amplified 1E+6-fold or more in about five minutes.

### Claim 72 (depends on 42)

The method of claim 42, wherein the target nucleotide sequence is amplified 1E+6-fold or more in about 2.5 minutes.

### Claim 73 (depends on 42)

The method of claim 42, wherein the target nucleotide sequence is amplified 1E+7-fold or more in about five minutes.

### Claim 74 (depends on 42)

The method of claim 42, wherein the target nucleotide sequence is amplified 1E+8-fold or more in about five minutes.

### Claim 75 (depends on 42)

The method of claim 42, wherein the target nucleotide sequence is amplified 1E+9-fold or more in about five minutes.

### Claim 76

A system configured to amplify a target nucleotide sequence under essentially isothermal conditions and comprising an amplification reagent mixture, the amplification reagent mixture comprising:
i. a polymerase,
ii. one or more nicking enzymes,
iii. a first oligonucleotide comprising a 5′ portion that comprises a nicking site that is non-complementary to the target nucleotide sequence and a 3′ portion that hybridizes to the target nucleotide sequence, and
iv. a second oligonucleotide comprising a 5′ portion that comprises a nicking site that is non-complementary to the target nucleotide sequence and a 3′ portion that hybridizes to the target nucleotide sequence;
and wherein the target nucleotide sequence is between 20 and 40 nucleotides in length.

### Claim 77 (depends on 76)

The system of claim 76, further configured to amplify the target nucleotide sequence 1E+6-fold or more in about in about ten minutes.

### Claim 78 (depends on 76)

The system of claim 76, wherein the amplification reagent mixture contains no oligonucleotides other than the first oligonucleotide and the second oligonucleotide.

### Claim 79 (depends on 76)

The system of claim 76, further configured to detect the amplified target nucleotide sequence.

### Claim 80 (depends on 79)

The system of claim 79, wherein detecting the amplified target nucleotide sequence occurs within about 10 minutes or less of combining a target nucleotide sequence with the amplification reagent mixture under essentially isothermal conditions.

### Claim 81 (depends on 76)

The system of claim 76, wherein detecting amplified target nucleotide sequence occurs in real time.

### Claim 82 (depends on 76)

The system of claim 76, further configured to amplify a target nucleic acid present in a sample from an animal, plant or food.

### Claim 83 (depends on 76)

The system of claim 76, further configured to amplify a target nucleic acid of a human pathogen present in a sample of mucus, sputum, or saliva obtained from a human.
